30 Years Of Covering Mumbai
Home > Business > Cipla Gets US FDA Approval For World’s First Paediatric Medicine For Treatment of AIDS In Children

Cipla Gets US FDA Approval For World’s First Paediatric Medicine For Treatment of AIDS In Children

Thursday, June 04, 2015
By A Business Reporter

Cipla has announced that it has received US FDA approval for an innovative formulation — Lopinavir/ Ritonavir  oral pellets for paediatric specific for the treatment of aids in infants and young children. “Long recognizing the lack of access to life saving child-friendly formulations for the treatment of HIV”, the company says “Cipla was prompted to develop an innovative formulation in pellets form that can be sprinkled on sweetened porridge for infants and administered to them. The pellets are produced by melt-extrusion technology and are enclosed in capsules.”

Globally 3,200,000 children were living with HIV in 2013 and 240,000 children were newly infected with HIV (UNAIDS — The Gap Report 2014). Although antiretroviral therapy can be life saving for these children, only 24% are currently on treatment. One third of the children born with HIV without treatment die before their first birthday and 50% die before they turn two.

Commenting on the development, Subhanu Saxena, MD & Global CEO, Cipla Ltd. said: “We are extremely proud to have developed this innovative formulation of LPV/r oral pellets for infants and young children. Cipla has been committed to the cause of HIV/AIDS for over two decades. This innovative way of drug delivery through oral pellets for some of society’s youngest AIDS sufferers reiterates our commitment to provide access to life saving medicines in the fight against HIV/ AIDS.”

Dr Jaideep Gogtay, Chief Medical Officer, Cipla Ltd. said: “This unique drug delivery system is a breakthrough in paediatric specific treatment for infants. The traditionally available antiretroviral liquid formulations and tablets have their own challenges when it comes to treating infants.”

Dr Peter Mugyenyi, Executive Director of the Joint Clinical Research Centre (JCRC) in Uganda and a leading International authority on treatment of HIV/AIDS in Africa said: “I am delighted to hear of Cipla’s breakthrough in getting US FDA approval.  This product is a first step in making accessible more modern and appropriately formulated treatment available to the most vulnerable of HIV patients – young children.”

Facebook
Tweet
COMMENTS
No Comments Posted
POST YOUR COMMENTS
Name:
Email:
Comments:
 
City news
‘I am demanding that he should make an ...
NDA members carrying on a poster war outside ...
A 26-year-old boy — Ahmed Shaikh — who ...
I am 21 and my girlfriend who is also 21 (few mon
Dr. Rajan B. Bhonsle, M.D. (Bom)
Consulting Sex Therapist & Counsellor
Dr. (Mrs.) Minnu R. Bhonsle, Ph.D.
Consulting Psychotherapist & Counsellor
Astrology
Select Sun sign:
 
Aries (Mar 21 - Apr 20)
Aries (Mar 21 - Apr 20)An absorbing and financially beneficial day lies ahead. Travel is indicated for some of you and will turn out in your favor. An offer of work could come your way, which is totally different from what you do. A change is indicated but you will have to proceed cautiously. In pursuing your career goals you may have lost touch with love. A development today will make you realize how important it is for you.
Tarot for Love
Select Sun sign:
 
Aries (Mar 21 - Apr 20)
Aries (Mar 21 - Apr 20)What the cards say: Expand and be inclusive Path: Be a true friend. Don’t be focused on self Ally: Virgo will help you focus on service to others. Avoid reactive Leo or self centered Cancer Card for the week: Tarot key no. III The Empress. Love and all good things of life. The mother goddess of plenty brings abundance
- Advertising -
‘As property prices are rising, so are marriage d
Baaya Design was found by Shibani Jain in 2009.
When you’re going in for a realty purchase, chanc
Read More